{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:55:40Z","timestamp":1789707340761,"version":"4.0.1"},"reference-count":32,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:p>On February 24\u201327, 2021, the Association for Ocular Pharmacology and Therapeutics (AOPT) held its 15th biennial scientific meeting online. The meeting was organized by Dr. Sanjoy Bhattacharya of the University of Miami in conjunction with the board of trustees of the AOPT. The 3-day conference was attended by academic scientists, clinicians, and industry and regulatory professionals. The theme of the meeting was Restoring Vision through Regeneration and it was sponsored, in part, by the National Institutes of Health, Bright Focus, Regeneron, and Santen (USA). During the 3 days of the meeting, presentations from several sessions explored different aspects of regenerative medicine in ophthalmology, including optic nerve regeneration, drugs and devices in glaucoma, retinal neuroprotection and plasticity, visual perception, and degeneration of trabecular meshwork. This article summarizes the proceedings of the session on corneal regenerative medicine research and discusses emerging concepts in drug development for corneal epithelial and endothelial regeneration. Since the meeting in 2021, several of these concepts have advanced to clinical-stage therapies, but so far as of 2023, none has been approved by regional regulatory authorities in the United States. One form of corneal endothelial cell therapy has been approved in Japan and only for bullous keratopathy. Ongoing work is proceeding in the United States and other countries. Clinical Registration No: National Clinical Trials 04894110, 04812667; Japan Registry for Clinical Trials a031210199.<\/jats:p>","DOI":"10.1089\/jop.2023.0044","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T11:14:37Z","timestamp":1695294877000},"page":"551-562","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of Anterior Segment Focused Biologic Therapies to Regenerate Corneal Tissue for the Treatment of Disease: Drug Development Experience"],"prefix":"10.1177","volume":"39","author":[{"given":"Cheryl","family":"Rowe-Rendleman","sequence":"first","affiliation":[{"name":"Omar Consulting Group, LLC, Durham, North Carolina, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eveleth","sequence":"additional","affiliation":[{"name":"Trefoil Therapeutics, San Diego, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Stanford University, Stanford, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ula","family":"Jurkunas","sequence":"additional","affiliation":[{"name":"Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okumura","sequence":"additional","affiliation":[{"name":"Doshisha University, Kyotanabe, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dawson","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville, Florida, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar B.","family":"Sawant","sequence":"additional","affiliation":[{"name":"Center for Vision and Eye Banking Research, Eversight, Cleveland, Ohio, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.09.017"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e318250884e"},{"key":"e_1_3_4_4_2","first-page":"1","volume-title":"A Synopsis of Ophthalmology","author":"Martin-Doyle JLC","year":"1971","unstructured":"Martin-Doyle JLC. Chapter 1\u2014The routine examination of an ophthalmic patient. In: A Synopsis of Ophthalmology, 4th ed. (JLC Martin-Doyle. ed.) John Wright & Sons: Bristol, UK; 1971; pp. 1\u20138."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2007.02.001"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.09.008"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.08.002"},{"issue":"71","key":"e_1_3_4_8_2","first-page":"33","article-title":"Corneal blindness: Prevention, treatment and rehabilitation","volume":"22","author":"Burton MJ","year":"2009","unstructured":"Burton MJ. Corneal blindness: Prevention, treatment and rehabilitation. Com Eye Health, 2009; 22(71):33\u201335.","journal-title":"Com Eye Health"},{"key":"e_1_3_4_9_2","first-page":"e3847","article-title":"Corneal donor tissue preparation for endothelial keratoplasty","volume":"64","author":"Woodward MA","year":"2012","unstructured":"Woodward MA, , Titus M, , Mavin K, et al. Corneal donor tissue preparation for endothelial keratoplasty. J Vis Exp, 2012; 64:e3847; doi: 10.3791\/3847","journal-title":"J Vis Exp"},{"key":"e_1_3_4_10_2","unstructured":"2021 Eye Banking Statistical Report. (n.d.). Eye Bank Association of America. Available from: www.corneas.org\/repository\/images\/pressimages\/EBAA%202009%20Statistical%20Report%20-%20Final.pdf [Last accessed: March3 2023]."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S284617"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002741"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002748"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0408"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8620172"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092302"},{"key":"e_1_3_4_17_2","unstructured":"Moshirfar M Thomson AC Ronquillo YC. Corneal Endothelial Transplantation. Treasure Island Fl USA; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562265\/ [Last accessed: March7 2023]."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.4776"},{"issue":"11","key":"e_1_3_4_19_2","first-page":"879","article-title":"[Cultured human corneal endothelial cell transplantation]","volume":"110","author":"Mimura T","year":"2006","unstructured":"Mimura T. [Cultured human corneal endothelial cell transplantation]. Nippon Ganka Gakkai Zasshi, 2006; 110(11):879\u2013897.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"13","key":"e_1_3_4_20_2","first-page":"1817","article-title":"A ROCK inhibitor enhances corneal endothelial wound healing in both an in vitro and in vivo model","volume":"50","author":"Okumura N","year":"2009","unstructured":"Okumura N, , Koizumi N, , Ueno M, et al. A ROCK inhibitor enhances corneal endothelial wound healing in both an in vitro and in vivo model. Invest Ophthalmol Vis Sci, 2009; 50(13):1817.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.03.033"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep26113"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.09.002"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-26001"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017452"},{"issue":"13","key":"e_1_3_4_26_2","first-page":"2429","article-title":"Ocular toxicity of magnetic nanoparticles","volume":"50","author":"Raju HB","year":"2009","unstructured":"Raju HB, , Hu Y, , Vedula AS, et al. Ocular toxicity of magnetic nanoparticles. Invest Ophthalmol Vis Sci, 2009; 50(13):2429.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_27_2","first-page":"2255","article-title":"Clinical grade magnetic human corneal endothelial cells for cell therapy","volume":"59","author":"Kuzmenko O","year":"2018","unstructured":"Kuzmenko O, , Bartakova A, , Kunzevitzky NJ, et al. Clinical grade magnetic human corneal endothelial cells for cell therapy. Invest Ophthalmol Vis Sci, 2018; 59:2255.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2019.0119"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3791\/63482"},{"key":"e_1_3_4_30_2","unstructured":"Chen XW. The effects of rhTGF-\u03b21 on corneal wound healing in a rabbit model. 2017;16(5):5897\u20135902."},{"issue":"6","key":"e_1_3_4_31_2","first-page":"5043","article-title":"The effect of rhEGF on corneal wound healing in a rabbit model","volume":"13","author":"Gao FC","year":"2016","unstructured":"Gao FC. The effect of rhEGF on corneal wound healing in a rabbit model. Mol Med Rep, 2016; 13(6):5043\u20135049.","journal-title":"Mol Med Rep"},{"key":"e_1_3_4_32_2","first-page":"1","article-title":"Corneal endothelial cell dysfunction: etiologies and management","volume":"10","author":"Feizi S.","year":"2018","unstructured":"Feizi S. Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol, 2018; 10:1\u201319.","journal-title":"Ther Adv Ophthalmol"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2014.12.002"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2023.0044","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2023.0044","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2023.0044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:45:48Z","timestamp":1777646748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2023.0044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10,1]]}},"alternative-id":["10.1089\/jop.2023.0044"],"URL":"https:\/\/doi.org\/10.1089\/jop.2023.0044","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,1]]}}}